Day: January 3, 2025

SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) — ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical’s presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 15, 2025 and Thursday, January 16, 2025. The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay. About ICU Medical ICU Medical (Nasdaq:ICUI)...

N2OFF will hold approximately 70% ownership in the projects, further enhancing its presence in the European energy storage market Neve Yarak, Israel, Jan. 03, 2025 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, announced today that on January 3 2025 it has signed a binding LOI with Solterra Ltd’s subsidiary ,Soltera Brand Services Italy (“SBSI”), a company that specializes in the origination and development of renewable energy projects in Italy (“Solterra Italy”). According to the terms of the LOI the Projects will include the purchase and development of 2 Battery Storage (“BESS”) systems in Sicily, each with a capacity of 98MWp/392MWh. The binding term sheet was executed following a...

PARIS, FRANCE, January 3rd, 2025 – Information on the total number of voting rights and shares in Tarkett’s share capital as of December 31st, 2024 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of December 31st, 2024 65,550,281 Number of theoretical voting rights: 123 799 221  Number of exercisable voting rights: 123 780 662*  * After deduction of the treasury shares without voting rights. *** Investor Relations Contact investors@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83 About Tarkett With a 140-year history, Tarkett is a worldwide...

Provides Update on 2024 Service Revenue Guidance TORONTO, Jan. 03, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) today issued a notice for its fourth quarter financial results and provided an update on its 2024 service revenue guidance. Fourth quarter financial results and 2025 outlookThe company plans to release its fourth quarter financial results and outlook for 2025 on Thursday, January 30, 2025, before North American financial markets open. The results will be distributed by newswire and posted at investors.rogers.com. Rogers’ management will host its quarterly teleconference with the investment community to discuss the results and outlook at 8:00 a.m. ET. A live webcast of the teleconference will be available on the Investor Relations section of Rogers’ website at investors.rogers.com. Alternatively,...

MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health;...

Group CTO Mikael Kärrsten has been granted 1,090 Tryg shares for a total amount of DKK 167,424. Granting of the shares are related to the acquisition TryggHansa in 2021Attachment01_2025.03.01 Transaction statement

Stockholm, 3rd of January 2025 – Today Virtune announces that it has finalized its monthly rebalancing for Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR-denominated (ISIN code SE0020052215, ticker name VIR10EUR) ETP. In addition to the Virtune Crypto Top 10 Index ETP, Virtune’s product portfolio includes:   Virtune Bitcoin ETPVirtune Staked Ethereum ETPVirtune Staked SolanaVirtune Staked Polkadot ETPVirtune XRP ETPVirtune Avalanche ETPVirtune Chainlink ETPVirtune Arbitrum ETPVirtune Staked Polygon ETP Virtune Staked Cardano ETPVirtune Crypto Altcoin Index ETP Index allocation as of 30th of December (before rebalancing): Bitcoin: 40.55%Ethereum: 34.51%XRP: 9.62%Solana: 8.95%Cardano: 2.69%Avalanche: 1.35%Chainlink: 1.13%Litecoin:...

Martela Corporation, inside information, 3.1.2025, at 10:25 The continued challenging market situation in recent years has affected Martela’s operating environment, weakening the volumes and profitability of Martela’s business. The economic recovery that has begun will have a positive impact on the situation in the sector, but the strength of the recovery still includes uncertainties in the main market areas.   For the above reasons, Martela plans to streamline and reorganize its operations in order to mitigate the adverse effects of the market situation, to adjust its cost structure to the prevailing conditions and to bring flexibility in the face of demand uncertainties. According to a preliminary estimate, the planned measures may lead to a permanent reduction of approximately 20 positions. The planned actions concern Martela...